<<A buying program, let alone an order, for 300,000+ shares would have driven up the price by a wide margin. Hence the unreality of your UNVC position.>>
Hmmm. That's a bizarre and highly selective stance since you didn't seem to flick a sanctimonious eyelash when an 'order' was put in to buy almost 14,000 shares of a $1.46 stock
There is a difference, clear to almost everyone, between (1) a 14,000 share order for VPHM, which trades on average, according to Yahoo, more than 120,000 shares a day], and (2) a 325,000 share order for UNVC.OB, which trades on average fewer than 28,000 shares a day. It's the difference between about 12% of daily volume and about 12 times daily volume. The first could likely be executed with little or no effect on price; the second plainly couldn't. This doesn't seem hard.
To dismiss this distinction as bizarre and highly selective, and to say that those who see the distinction are sanctimonious for seeing it -- i.e., to generally run to ad hominem attacks when you have little or no logic on your side -- well, no wonder you have trouble getting your arguments taken seriously or treated with respect. (Even apart from your extensive SI history.)
SEPR -- it is a reasonable question whether SEPR is a "biotech", or rather more a pharmaceutical. (Mostly it is thought of with the biotechs: it trades like them, generally, probably because it is in the early stages of developing therapeutics -- i.e., with a business plan and financing structure closer to NBIX or MLNM than MRK or PFE.)
But whether SEPR is a biotech or not, the point doesn't help your stance. UNVC, which apparently makes and sells syringes and other medical devices, and offers other "assistance" to providers of medical services, is plainly not a biotech under anyone's reasonable definition. You're not seriously arguing that if we think of SEPR as a biotech, then we have no conceivable basis for excluding anything from the stocks admissible into the contest? (Hell, I'd have listed my favorite power company, RRI, if I'd had such a flexible view of the rules.) |
